Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization zuo2020alterations

The author measured SARS-CoV-2 detected by real-time reverse transcriptase PCR in fecal samples from 15 hospitalized COVID-19 patients in Hong Kong.

Analytes

stool_SARSCoV2_SymptomOnset

SARS-CoV-2 RNA gene copy concentrations in fecal samples, which were were collected 2 to 3 times per week starting from hospital admission, and SARS-CoV-2 detection in feces was tracked longitudinally. The day is calculated relative to the date of symptom onset. The concentrations were quantified in gene copies per mL.

Biomarker: SARS-CoV-2
Specimen: stool
Units: gc/mL
Gene target: N1
Participants: 12
Negative samples: 21
Positive samples (not quantifiable): 0
Quantifiable samples: 19
Limit of quantification: unknown
Limit of detection: 347

stool_SARSCoV2_ConfirmationDate

SARS-CoV-2 RNA gene copy concentrations in fecal samples, which were were collected 2 to 3 times per week starting from hospital admission, and SARS-CoV-2 detection in feces was tracked longitudinally. The day is calculated relative to the date of SARS-CoV-2 confirmation. The concentrations were quantified in gene copies per mL.

Biomarker: SARS-CoV-2
Specimen: stool
Units: gc/mL
Gene target: N1
Participants: 3
Negative samples: 5
Positive samples (not quantifiable): 0
Quantifiable samples: 7
Limit of quantification: unknown
Limit of detection: 347